COL1A1 and breast carcinoma: The previously reported GWAS variants (consortia SNPs), except COL1A1-rs2075555, remained statistically significant in subgroups with both pre and postmenopausal women, luminal A cases, cases with or without family history of breast cancer, low tumor grade and operable tumor stage at adjusted P<0.05 (Table S2).